Association of ABO Blood Group and Risk of Lung Cancer in a Multicenter Study in Turkey
dc.contributor.author | Urun, Yuksel | |
dc.contributor.author | Utkan, Gungor | |
dc.contributor.author | Cangir, Ayten Kayi | |
dc.contributor.author | Oksuzoglu, Omur Berna | |
dc.contributor.author | Ozdemir, Nuriye | |
dc.contributor.author | Oztuna, Derya Gokmen | |
dc.contributor.author | Kocaman, Gokhan | |
dc.date.accessioned | 2024-04-24T17:28:17Z | |
dc.date.available | 2024-04-24T17:28:17Z | |
dc.date.issued | 2013 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | Background: The ABO blood groups and Rh factor may affect the risk of lung cancer. Materials and Methods: We analyzed 2,044 lung cancer patients with serologically confirmed ABO/Rh blood group. A group of 3,022,883 healthy blood donors of Turkish Red Crescent was identified as a control group. We compared the distributions of ABO/Rh blood group between them. Results: The median age was 62 years (range: 17-90). There was a clear male predominance (84% vs. 16%). Overall distributions of ABO blood groups were significantly different between patients and controls (p=0.01). There were also significant differences between patients and controls with respect to Rh positive vs. Rh negative (p=0.04) and O vs. non-O (p=0.002). There were no statistically significant differences of blood groups with respect to sex, age, or histology. Conclusions: In the study population, ABO blood types were associated with the lung cancer. Having non-O blood type and Rh-negative feature increased the risk of lung cancer. However, further prospective studies are necessary to define the mechanisms by which ABO blood type may influence the lung cancer risk. | en_US |
dc.identifier.doi | 10.7314/APJCP.2013.14.5.2801 | |
dc.identifier.endpage | 2803 | en_US |
dc.identifier.issn | 1513-7368 | |
dc.identifier.issue | 5 | en_US |
dc.identifier.pmid | 23803034 | |
dc.identifier.scopus | 2-s2.0-85047687658 | |
dc.identifier.scopusquality | Q3 | |
dc.identifier.startpage | 2801 | en_US |
dc.identifier.uri | https://doi.org/10.7314/APJCP.2013.14.5.2801 | |
dc.identifier.uri | https://hdl.handle.net/11468/20390 | |
dc.identifier.volume | 14 | en_US |
dc.identifier.wos | WOS:000331473400019 | |
dc.identifier.wosquality | Q4 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Asian Pacific Organization Cancer Prevention | en_US |
dc.relation.ispartof | Asian Pacific Journal of Cancer Prevention | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Abo Blood | en_US |
dc.subject | Group System | en_US |
dc.subject | Lung Neoplasms | en_US |
dc.subject | Cancer | en_US |
dc.subject | Risk Factors | en_US |
dc.title | Association of ABO Blood Group and Risk of Lung Cancer in a Multicenter Study in Turkey | en_US |
dc.title | Association of ABO Blood Group and Risk of Lung Cancer in a Multicenter Study in Turkey | |
dc.type | Article | en_US |